Marinomed Biotech AG: Changes in the total number of voting rights and share capital in accordance with Article 135 paragraph 1 BörseG
EQS Comprehensive Voting Rights Notice: Marinemed Biotech AG / publication
Total number of voting rights
Marinemed Biotech AG: Changes in the total number of voting rights and
Capital according to Article 135 paragraph 1 BörseG
31 March 2024 at 10:00 CET/CET
Publication of the total number of voting rights in accordance with Article 135 paragraph 1 BörseG
It is carried by EQS News – a service of EQS Group AG.
The source/publisher is responsible for the content of the message.
Marinemed Biotech AG hereby informs that due to implementation
of convertible bonds with Nice & Green total no
Voting rights at the end of March 2024 total 1,540,530 voting rights
The company's new capital has been increased to €1,540,530.
Change in total number of voting rights since March 27, 2024
effective.
March 31, 2024 CET/Central European Time
German language
Company: Marinemed Biotech AG
Hoffingass 25
2100 Korneuburg
Austria
Internet: www.marinomed.com
End of message EQS News Service
1869389 03/31/2024 CET/Central European Time
ISIN ATMARINOMED6
AXC0005 2024-03-31/10:00
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage is not permitted without the prior express consent of dpa-AFX.
“Total coffee aficionado. Travel buff. Music ninja. Bacon nerd. Beeraholic.”
More Stories
Wealthy families take more risks when it comes to money.
Salesforce and NVIDIA Form Strategic Collaboration to Drive AI Customer Innovation
Changing banks causes problems for customers